The adenosine A<sub>2A</sub> receptor is a therapeutic target in neurological, heart and oncogenic diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The adenosine A_2A receptor is a therapeutic target in neurological, heart and oncogenic diseases

Published:2022-09-02 Issue:9 Volume:26 Page:791-800
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Franco Rafael¹²³,Lillo Alejandro¹⁴,Navarro Gemma¹⁴,Reyes-Resina Irene¹³⁴

Affiliation:

1. CiberNed, Network Center for Neurodegenerative diseases, National Spanish Health Institute Carlos III, Madrid, Spain

2. Molecular Neurobiology laboratory, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain

3. School of Chemistry, Universitat de Barcelona, Barcelona, Spain

4. Molecular Neuropharmacology laboratory, Department of Biochemistry and Physiology. School of Pharmacy and Food Science, Universitat de Barcelona, Barcelona, Spain

Funder

European Union Next Generation EU/PRTR’

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2022.2136570

Reference166 articles.

1. Evolutionary origins of the purinergic signalling system

2. Early evolutionary history (from bacteria to hemichordata) of the omnipresent purinergic signalling: A tribute to Geoff Burnstock inquisitive mind

3. A model for adenosine transport and metabolism

4. Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP